Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
MRM Health Initiates Clinical Research in Parkinson’s Disease
Tuesday, February 20, 2024MRM Health a clinicalstage biopharmaceutical company announced today that it has received regulatory and ethics committee approval to start an observational crosssectional clinical trial to study the role of the small intestinal microbiome Parkinsons...
Ultimovacs Receives EMA Orphan Drug Designation for UV1 Cancer Vaccine for the Treatment of Mesothelioma
Monday, February 19, 2024Ultimovacs ASA a clinicalstage biotechnology leader in novel immunotherapeutic cancer vaccines today announced that the European Medicines Agency has issued a positive opinion on the companys application for Orphan Drug Designation
First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure
Saturday, February 17, 2024Bayer AG and Asklepios BioPharmaceutical Inc a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG today announced that the first patient has been randomized in GenePHIT
Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted Radiotherapy
Saturday, February 17, 2024Fusion Pharmaceuticals Inc a clinicalstage oncology company focused on developing nextgeneration radiopharmaceuticals as precision medicines today announced that it has entered into an exclusive worldwide license agreement
Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company
Friday, February 16, 2024Avicanna Inc a biopharmaceutical company focused on the development manufacturing and commercialization of plantderived cannabinoidbased products is pleased to announce it has entered into a research collaboration
Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-1664
Friday, February 16, 2024Repare Therapeutics Inc a leading clinicalstage precision oncology company today announced the first patient has been dosed in the Companys Phase LIONS clinical trial evaluating RP a potential firstinclass
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
Thursday, February 15, 2024Erasca Inc a clinicalstage precision oncology company singularly focused on discovering developing and commercializing therapies for patients with RASMAPK pathwaydriven cancers today announced two clinical trial collaboration and supply
TheracosBio Extends Partnership with Mark Cuban Cost Plus Drug Company
Thursday, February 15, 2024TheracosBio today announced that it is extending its collaboration with the Mark Cuban Cost Plus Drug Company Under the partnership BRENZAVVY is available directly to healthcare businesses under the Cost Plus Drugs
Medicenna Announces First Patient Dosed in ABILITY-1 Study of MDNA11 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors
Wednesday, February 14, 2024Medicenna Therapeutics Corp a clinicalstage immunotherapy company focused on the development of Superkines today announced the first patient dosed in the combination arm of the Phase
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy for Sickle Cell Disease and Beta Thalassemia
Wednesday, February 14, 2024CRISPR Therapeutics a biopharmaceutical company focused on creating transformative genebased medicines for serious diseases announced today that the European Commission has granted conditional marketing authorization
